Cyrus Mirsaidi
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Radiomics and Machine Learning in Medical Imaging, Cancer Research and Treatments, Cancer-related Molecular Pathways
Most-Cited Works
- → PP 64 Predictive assays for targeted therapeutics using image-based high content analysis of patient-derived tumor models(2011)1 cited
- → Abstract 3224: Molecular Response LLC tumor bank and patient-derived tumor xenograft models: a powerful translational engine for discovery and development of novel oncology therapeutics(2015)1 cited
- → Abstract 5767: Ex vivo three-dimensional tumor growth assay: 3DX-TGA(2017)1 cited
- → Abstract 1189: Establishment of patient-derived xenograft (PDX) models for small cell lung cancer (SCLC) as a preclinical platform for drug development(2014)1 cited
- → Abstract 1224: A patient derived xenograft (PDX) platform for development of next generation KIT kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors (GIST)(2014)1 cited
- → 178 Establishment of patient-derived xenografts (PDX) models for small cell lung (SCL) as a pre-clinical platform for drug development(2014)
- → Abstract 3611: Identifying gene expression markers of anticancer drug response using large scale genomic and drug response databases established from patient derived tumors(2012)
- → Abstract 3221: Development of patient-derived xenograft (PDX) models for gastrointestinal stromal tumors (GIST) as a pre-clinical platform for drug development(2015)
- → Abstract 4209: Development of patient-derived xenograft (PDX) models for small cell lung cancer (SCLC) as a preclinical platform for drug development(2015)
- → Abstract 881: Leveraging the molecular heterogeneity of patient-derived tumor samples to simulate clinical trial settings and model combination treatments(2012)